Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.75 EUR | +0.64% | +2.94% | +14.96% |
Apr. 25 | Kromek rises on USD2.9 million order from US federal customer | AN |
Apr. 25 | AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract | AN |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company is in a robust financial situation considering its net cash and margin position.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+14.96% | 245M | C | ||
-3.25% | 15.01B | - | ||
-38.91% | 2.8B | C- | ||
-12.68% | 2.45B | - | ||
-12.18% | 1.46B | - | - | |
-.--% | 1.12B | - | - | |
+46.70% | 534M | - | ||
-13.03% | 203M | - | - | |
+2.59% | 187M | - | ||
-.--% | 168M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DETEC Stock
- Ratings Detection Technology Oyj